Empagliflozin therapy for TYPE 2 DIABETES: Viewing possible Benefits in relative and absolute terms
Kumana, C.R., Cheung, B.M.Y.Volume:
39
Language:
english
Journal:
Clinical Therapeutics
DOI:
10.1016/j.clinthera.2017.05.065
Date:
August, 2017
File:
PDF, 59 KB
english, 2017